Parkinson’s treatment targeted in latest pay-for-delay suit

Two generic manufacturers have sued speciality prescription companies US WorldMeds, Supernus and Britannia Pharmaceuticals for allegedly maintaining an unlawful monopoly over a Parkinson’s disease medication.

Unlock unlimited access to all Global Competition Review content